The release of data on electoral bonds by the Election Commission, as mandated by the Supreme Court, has shed light on concerning contributions from pharmaceutical companies, particularly Hetero Drugs, a major manufacturer of Remdesivir, a drug crucial in treating COVID-19 patients.